- Home
- EVC vs SCPH Comparison
EVC vs SCPH Comparison
Compare EVC & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVC
- SCPH
- Stock Information
- Founded
- EVC 1996
- SCPH 2013
- Country
- EVC United States
- SCPH United States
- Employees
- EVC N/A
- SCPH N/A
- Industry
- EVC Broadcasting
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- EVC Industrials
- SCPH Health Care
- Exchange
- EVC Nasdaq
- SCPH Nasdaq
- Market Cap
- EVC 188.3M
- SCPH 173.6M
- IPO Year
- EVC 2000
- SCPH 2017
- Fundamental
- Price
- EVC $2.53
- SCPH $4.48
- Analyst Decision
- EVC
- SCPH Strong Buy
- Analyst Count
- EVC 0
- SCPH 3
- Target Price
- EVC N/A
- SCPH $14.00
- AVG Volume (30 Days)
- EVC 273.8K
- SCPH 268.4K
- Earning Date
- EVC 08-07-2025
- SCPH 08-13-2025
- Dividend Yield
- EVC 7.97%
- SCPH N/A
- EPS Growth
- EVC N/A
- SCPH N/A
- EPS
- EVC N/A
- SCPH N/A
- Revenue
- EVC $378,623,000.00
- SCPH $41,982,000.00
- Revenue This Year
- EVC $64.06
- SCPH $108.95
- Revenue Next Year
- EVC N/A
- SCPH $73.83
- P/E Ratio
- EVC N/A
- SCPH N/A
- Revenue Growth
- EVC 23.10
- SCPH 138.10
- 52 Week Low
- EVC $1.58
- SCPH $1.94
- 52 Week High
- EVC $2.73
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- EVC 63.49
- SCPH 68.38
- Support Level
- EVC $2.19
- SCPH $3.96
- Resistance Level
- EVC $2.60
- SCPH $4.57
- Average True Range (ATR)
- EVC 0.10
- SCPH 0.20
- MACD
- EVC 0.01
- SCPH 0.03
- Stochastic Oscillator
- EVC 79.17
- SCPH 88.72
About EVC Entravision Communications Corporation
Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.